Blog
The challenge of detecting early Alzheimer’s disease for clinical trials
In this post, Director of Clinical Affairs, Dr Kenton Zavitz, looks at the challenge of recruiting the correct patients into Alzheimer's disease trials.
web-based testing,
wearables,
virtual clinical trials,
technology,
swm,
subjective measures,
stigma,
social cognition,
smartphones,
schizophrenia research,
schizophrenia,
safety,
rvp,
rti,
research funding,
research,
remote testing,
regulations,
recruitment,
rare disease,
prodromal,
pro-cognitive,
prm,
press release,
presenteeism,
precision psychiatry,
pre-clinical,
poster,
personalised medicine,
patient recruitment,
patient engagement,
parkinson's disease,
pal,
paired associates learning,
ots,
occupational health,
normative data,
neuroscience,
neurology,
near-patient testing,
multiple sclerosis,
mts,
ms,
modelling,
mental wellbeing,
mdd,
mci,
major depression,
high-frequency testing,
high frequency,
healthcare,
guide,
grant,
funding,
fatigue,
ert,
epidemiology,
ebt,
early career researchers,
early alzheimer's disease,
drug development,
dms,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive testing,
cognitive science,
cognitive safety,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab,
brain health,
biomarkers,
awards,
automatic speech recognition,
autism,
attention,
asr,
asd,
alzheimer's disease,
adolescents,
academic,
absenteeism,
